SBRA
Sabra Health Care REIT, Inc.
SBRA's fundamentals are mixed: revenue grew 23%, but its operating margin fell 16 points to 7.1%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
SBRA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| N/A | |
| N/A |
SBRA's revenue is currently strong, and its profitability is stable. Free cash flow and net leverage aren't meaningful measures for real estate companies like SBRA.
SBRA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 24x | $6.78 | -67% |
| Forward | 29x | $20.56 | — |
| Fair | 31x | $8.76 | -57% |
| Current | 73x | $20.56 | — |
| Expensive | 78x | $21.96 | +6.8% |
Historical ranges are pointers, not guarantees.
SBRA's PE is 73x, but its earnings don't support one, so it isn't a reliable read right now.
SBRA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for SBRA, but weaker profitability.
SBRA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.71 | +155% |
| Q3 2026 | $0.28 | -62% |
| Q2 2026 | $0.26 | -66% |
| Q1 2026 | $0.63 | +5% |
| Q4 2025 | $0.64 | +19% |
| Q3 2025 | $0.73 | +74% |
| Q2 2025 | $0.77 | +250% |
| Q1 2025 | $0.60 | +186% |
| Q4 2024 | $0.54 | +800% |
SBRA's earnings per share have fallen from their peak: $0.28 over the past year, against $0.98 in early 2020. Its recent earnings include one-off gains.
SBRA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $249.6M | +31% |
| Q2 2026 | $235.9M | +25% |
| Q1 2026 | $221.8M | +21% |
| Q4 2025 | $211.9M | +16% |
| Q3 2025 | $190M | +6.8% |
| Q2 2025 | $189.2M | +7.4% |
| Q1 2025 | $183.5M | +10% |
| Q4 2024 | $182.3M | +12% |
SBRA's revenue has grown year over year for 11 quarters in a row: $250M last quarter, up 31% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | -0.8 points |
| Q2 2026 | -11% | -46 points |
| Q1 2026 | 18% | -4.3 points |
| Q4 2025 | 12% | -14 points |
| Q3 2025 | 11% | -5 points |
| Q2 2025 | 34% | +21 points |
| Q1 2025 | 22% | +5.7 points |
| Q4 2024 | 26% | +15 points |
SBRA's operating margin was 11% last quarter, down 0.8 points from the same quarter a year ago.
SBRA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $129M | +29% |
| Q2 2026 | $85.8M | +6% |
| Q1 2026 | $98.4M | +23% |
| Q4 2025 | $87.4M | +9.3% |
| Q3 2025 | $100M | +2.4% |
| Q2 2025 | $81M | +1% |
| Q1 2025 | $80.3M | +52% |
| Q4 2024 | $80M | +1.6% |
SBRA's free cash flow was $401M over the past year, up 17% from the year before. Free cash flow isn't a meaningful measure for real estate companies like SBRA.
SBRA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3% | +7.6M shares |
| 1 year | +6.7% | +16.3M shares |
| 3 years | +12% | +28.6M shares |
| 5 years | +17% | +37.8M shares |
| Available history | +38% | +71.7M shares |
SBRA has 260M diluted shares, up 6.7% from a year ago.
SBRA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 8.3x | High |
| Q2 2026 | 8.9x | High |
| Q1 2026 | 7.3x | High |
| Q4 2025 | 7.2x | High |
| Q3 2025 | 6.8x | High |
| Q2 2025 | 6.7x | High |
| Q1 2025 | 7.6x | High |
| Q4 2024 | 7.9x | High |
SBRA's net debt is about 8.3 years of its operating earnings (EBITDA), up from 6.8 years a year ago. Net leverage isn't a meaningful measure for real estate companies like SBRA.
SBRA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.1 | Neutral |
| Stochastic | 58.4 | Neutral |
SBRA's weekly RSI is 54 (neutral) and its Stochastic is 58 (neutral).
SBRA PE vs Real Estate Sector
| Metric | SBRA | Sector median | Relative |
|---|---|---|---|
| PE | 73x | 24x | 207% above |
| PE % | 75 | 23 | 52 pts above |
SBRA is trading at 73x earnings, a 207% premium to the Real Estate sector's median of 24x, though its earnings don't support one.
SBRA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $19.8 | 4% above |
| 20 week MA | $20.3 | 1.5% above |
| 50 week MA | $19.9 | 3.4% above |
| 100 week MA | $18.9 | 9% above |
| 200 week MA | $16.6 | 24% above |
SBRA is in an uptrend: it's above all five of its weekly moving averages, and 24% above its 200-week average.
SBRA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $20.9 | $17.8 | -15% |
| 2021 | $17.8 | $13.2 | -26% |
| 2022 | $13.2 | $12.5 | -5.4% |
| 2023 | $12.5 | $14.3 | +14% |
| 2024 | $14.3 | $17.0 | +19% |
| 2025 | $17.0 | $18.8 | +10% |
| 2026 YTD | $18.8 | $20.6 | +9.4% |
SBRA has finished lower in three of the last six years. It's up 9.4% so far in 2026.